Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model
- 30 June 2002
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 42 (8), 1056-1064
- https://doi.org/10.1016/s0028-3908(02)00049-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding SequenceMolecular and Cellular Biology, 2000
- Oxidative Stress Induces DNA Fragmentation and Caspase Activation Via the c-Jun NH2-terminal Kinase Pathway in H9c2 Cardiac Muscle CellsJournal of Molecular and Cellular Cardiology, 1998
- Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous systemJournal of Comparative Neurology, 1997
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic cultureJournal of Neuroscience Research, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- IV. MPTP, MPP+ and mitochondrial functionLife Sciences, 1987
- Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+Biochemical and Biophysical Research Communications, 1986